Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Reprogramming glutamine metabolism enhances BCMA -CAR T-cell fitness and therapeutic efficacy in multiple myeloma

Blood (2025) 146 (24): 2931–2944.

https://doi.org/10.1182/blood.2024027496

Published: 2025

Includes: Supplemental data

Journal Articles

Innovative sdab-based CAR-T cells targeting BCMA outperform current CAR-T therapies for multiple myeloma

Vianca Ibarra-Garcia, Maria Erendira Calleja-Cervantes, Eva Molina, Franco Bernasconi-Bisio, Federica Rochira, Iñigo Azagra-Barber, Ines Ibañez-Sala, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Lucia Vanrell, Juan Lasarte, Ana Alfonso-Pierola, Paula Rodriguez-Otero, Jesus San-Miguel, Juan Roberto Rodriguez-Madoz, Antonio Pineda-Lucena, Felipe Prosper

Blood (2025) 146 (Supplement 1): 4072.

https://doi.org/10.1182/blood-2025-4072

Published: 2025

Journal Articles

Single-cell multiomic dissection of human hematopoietic stem cells reveals novel transcriptional fingerprints and regulatory programs in bone marrow and mobilized peripheral blood

Blood (2025) 146 (Supplement 1): 1377.

https://doi.org/10.1182/blood-2025-1377

Published: 2025

Journal Articles

A functional CAR-T cell atlas to unravel regulatory mechanisms of CAR-T therapies

Sergio Camara-Peña, Paula Rodriguez Marquez, Nuria Planell, Maria Erendira Calleja-Cervantes, Lorea Jordana-Urriza, Giacomo Cinnirella, Shlomit Reich-Zeliger, Nir Yosef, Idoia Ochoa, Juan Roberto Rodriguez-Madoz, Mikel Hernáez Arrazola, Felipe Prosper

Blood (2025) 146 (Supplement 1): 5889.

https://doi.org/10.1182/blood-2025-5889

Published: 2025

Journal Articles

Molecular Mechanisms Promoting Long-Term Cytopenia after BCMA CAR-T Therapy in Multiple Myeloma

Blood (2024) 144 (Supplement 1): 4798.

https://doi.org/10.1182/blood-2024-207990

Published: 2024

Journal Articles

Identification and Evaluation of Novel Sdab-Based CAR-T Cells Against BCMA with Improved Therapeutic Efficacy for Multiple Myeloma

Vianca Ibarra-Garcia, Eva Molina, Franco Bernasconi-Bisio, Federica Rochira, Saray Rodríguez Diaz, Rebeca Martínez Turrillas, Paula Rodriguez-Marquez, Patricia Jauregui, Lucia Vanrell, Sara Villar, Paula Rodríguez-Otero, Juan J Lasarte, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Antonio Pineda-Lucena

Blood (2024) 144 (Supplement 1): 7155.

https://doi.org/10.1182/blood-2024-208103

Published: 2024

Journal Articles

Sequential Scmultiomics of In Vivo CAR-T Cells Allows Characterization of Transcriptional Differences between Patients, and Identifies IL10 As a Potential Mechanism of Resistance to CAR-T Cells in MM

Blood (2023) 142 (Supplement 1): 3433.

https://doi.org/10.1182/blood-2023-182887

Published: 2023

Journal Articles

Longitudinal Transcriptomic Analysis of CAR-T Cells at Single-Cell Level Allows the Identification of Molecular Mechanisms Promoting Long-Term CAR-T Cell Persistence in MM

Blood (2023) 142 (Supplement 1): 2069.

https://doi.org/10.1182/blood-2023-182933

Published: 2023

Journal Articles

A Multi-Omic Study Unveils a Clonal Population of TET2-Mutated Infiltrating T-Cells in Germinal Center B Cell Lymphomas (DLBCL and FL)

Sofia Huerga, Beñat Ariceta, Paula Aguirre-Ruiz, Patxi San-Martin, Sarai Sarvide, Marta Abengozar-Muela, Diego Alignani, Rocio Figueroa, Carlos Grande, Alvaro Lopez-Janeiro, Emma Muiños-Lopez, Juan Roberto Rodriguez-Madoz, Amaia Vilas-Zornoza, Felipe Prosper, Miguel Canales

Blood (2023) 142 (Supplement 1): 3003.

https://doi.org/10.1182/blood-2023-182830

Published: 2023

Journal Articles

Optimization of a Universal Allogeneic CAR-T Cells Combining CRISPR and Transposon-Based Technologies for Treatment of Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2023-189410

Published: 2023

Journal Articles

BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Multiple Myeloma Patients

Blood (2022) 140 (Supplement 1): 12708–12710.

https://doi.org/10.1182/blood-2022-163149

Published: 2022

Journal Articles

Identification of Molecular Mechanisms Governing CAR-T Cell Response in MM Patients Using Single Cell Transcriptomics

Blood (2022) 140 (Supplement 1): 7366–7368.

https://doi.org/10.1182/blood-2022-163082

Published: 2022

Journal Articles

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Blood (2021) 138 (Supplement 1): 552.

https://doi.org/10.1182/blood-2021-148281

Published: 2021

Journal Articles

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Blood (2021) 138 (Supplement 1): 735.

https://doi.org/10.1182/blood-2021-148578

Published: 2021

Journal Articles

Risk of Febrile Neutropenia (FN) in Select Myelosuppressive Chemotherapy Regimens

Leila Family, PhD, Su-Jau Yang, Zandra Klippel, MD, Yanli Li, MD PhD, John H Page, MD ScD, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2015) 126 (23): 3257.

https://doi.org/10.1182/blood.V126.23.3257.3257

Published: 2015

Journal Articles

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Hairong Xu, MD, PhD, Lanfang Xu, MS, John H Page, MD ScD, Olivia Sattayapiwat, MS, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2014) 124 (21): 4822.

https://doi.org/10.1182/blood.V124.21.4822.4822

Published: 2014

Journal Articles

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Chun Chao, PhD, Lanfang Xu, MS, Olivia Sattayapiwat, MS, John H Page, MD ScD, Kimberly Cannavale, Roberto Rodriguez, MD, Chet Bohac, Hairong Xu, MD, PhD

Blood (2014) 124 (21): 6007.

https://doi.org/10.1182/blood.V124.21.6007.6007

Published: 2014

Journal Articles

Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma

Chun Chao, PhD, John H Page, MD, ScD, Roberto Rodriguez, MD, Su-Jau Yang, PhD, Julie Huynh, MD, Victoria M Chia, PhD

Blood (2012) 120 (21): 3671.

https://doi.org/10.1182/blood.V120.21.3671.3671

Published: 2012

Journal Articles

A Prospective Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft Vs. Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

Zaid Al-Kadhimi, MD, Zartash Gul, MD, Roberto Rodriguez, MD, Wei Chen, PhD, Alice Mitchell, BS, Muneer H. Abidi, MD, Lois Ayash, MD, Abhinav Deol, MD, Lawrence G Lum, MD, DSc, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2011) 118 (21): 4551.

https://doi.org/10.1182/blood.V118.21.4551.4551

Published: 2011

Journal Articles

Response: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 different conditioning regimens

Ryotaro Nakamura, Roberto Rodriguez, Sepideh Shayani, Pablo Parker, Stephen J. Forman

Blood (2010) 115 (21): 4317.

https://doi.org/10.1182/blood-2010-02-267260

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Reprogramming glutamine metabolism enhances BCMA -CAR T-cell fitness and therapeutic efficacy in multiple myeloma

Innovative sdab-based CAR-T cells targeting BCMA outperform current CAR-T therapies for multiple myeloma

Single-cell multiomic dissection of human hematopoietic stem cells reveals novel transcriptional fingerprints and regulatory programs in bone marrow and mobilized peripheral blood

A functional CAR-T cell atlas to unravel regulatory mechanisms of CAR-T therapies

Molecular Mechanisms Promoting Long-Term Cytopenia after BCMA CAR-T Therapy in Multiple Myeloma

Identification and Evaluation of Novel Sdab-Based CAR-T Cells Against BCMA with Improved Therapeutic Efficacy for Multiple Myeloma

Sequential Scmultiomics of In Vivo CAR-T Cells Allows Characterization of Transcriptional Differences between Patients, and Identifies IL10 As a Potential Mechanism of Resistance to CAR-T Cells in MM

Longitudinal Transcriptomic Analysis of CAR-T Cells at Single-Cell Level Allows the Identification of Molecular Mechanisms Promoting Long-Term CAR-T Cell Persistence in MM

A Multi-Omic Study Unveils a Clonal Population of TET2-Mutated Infiltrating T-Cells in Germinal Center B Cell Lymphomas (DLBCL and FL)

Optimization of a Universal Allogeneic CAR-T Cells Combining CRISPR and Transposon-Based Technologies for Treatment of Acute Myeloid Leukemia

BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Multiple Myeloma Patients

Identification of Molecular Mechanisms Governing CAR-T Cell Response in MM Patients Using Single Cell Transcriptomics

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Risk of Febrile Neutropenia (FN) in Select Myelosuppressive Chemotherapy Regimens

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma

A Prospective Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft Vs. Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

Response: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 different conditioning regimens

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only